细胞外囊泡在新生儿医学中的治疗潜力和转化挑战
Ali M Atoom1, Media Hamed-Ahmed2, Shaker Al-Hasnaawei3,4
1Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research Al-Ahliyya Amman University Amman Jordan.
Bioengineering & translational medicine
|January 23, 2026
概括
细胞外囊泡 (EVs) 对新生儿疾病 (如败血症和HIE) 具有治疗潜力. 解决特征和安全方面的挑战是临床准备和婴儿护理转型的关键.
科学领域:
- 新生儿医学 新生儿医学
- 生物技术是生物技术.
- 再生医学是一种再生医学.
背景情况:
- 细胞外囊泡 (EVs) 被研究为新生儿疾病的新疗法.
- 电动汽车具有有益于新生儿健康的抗炎,免疫调节和再生特性.
- 临床前模型显示,EVs可以减少新生儿的炎症和器官损伤.
研究的目的:
- 审查EVs在新生儿疾病中的治疗潜力.
- 识别基于 EV 的疗法的临床转化障碍.
- 强调对临床准备的标准化和安全评估的需要.
主要方法:
- 在新生儿疾病模型中对EV进行临床前研究的审查.
- 分析电动汽车特征,隔离和量化方面的挑战.
- 检查安全数据,包括前凝剂活性和血栓形成风险.
主要成果:
- 在新生儿模型中,EVs在减少炎症和保持组织完整性方面表现出有效性.
- 临床翻译的重大障碍包括不完整的EV表征和可变方法.
- 有限的安全数据,特别是关于血栓形成风险的数据,需要进一步调查.
结论:
- 在治疗新生儿败血症,死性肠球炎,HIE和BPD方面,EV具有前景.
- 对于临床应用,标准化EV隔离,特征和安全测试方法至关重要.
- 应对当前的挑战可能会导致针对弱势婴儿的基于电动汽车的变革性治疗方法.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.0K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.0K
Translation
155.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.9K
Translation
17.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.7K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K


